Navigation Links
CCS Medical Announces Agreement with LifeScan
Date:3/6/2013

FARMERS BRANCH, Texas, March 6, 2013 /PRNewswire/ -- CCS Medical announced today that is has entered into an agreement with LifeScan, Inc., to provide diabetes testing supplies to patients across the country. 

(Logo: http://photos.prnewswire.com/prnh/20130306/FL72774LOGO )

"This agreement means that CCS Medical is a LifeScan Direct Mail Order Supplier with the ability to serve all Medicare beneficiaries and many commercial plan members who use LifeScan products, such as LifeScan's OneTouch® Ultra® meter and test strips," said Dirk Allison , CCS Medical President and Chief Executive Officer. 

"This is a tremendous development for CCS Medical that will enhance our leadership role within the industry," said Allison.  "We are excited about our renewed partnership with an industry leader such as LifeScan, which serves to further validate our mission of providing high-quality products to our patients at a low price."  

About CCS Medical 
Established in 1994, CCS Medical is a rapidly growing provider of low-cost, high-quality products and services delivered directly to homes of patients with chronic conditions.  The company offers a single source solution for diabetes testing supplies, insulin pumps, catheters, ostomy supplies, advanced wound care dressings, incontinence supplies, and prescription medications.  CCS Medical's patient-centered model specializes in convenient home delivery, product education, and insurance processing.  CCS Medical is a privately held company and its largest shareholders are funds managed by Highland Capital Management, L.P.  More information is available at www.ccsmed.com.

 


'/>"/>
SOURCE CCS Medical
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Concord Medical to Report Fourth Quarter and Full Year 2012 Financial Results on March 20, 2013
2. Study: Surefire Medicals Technology Improves Delivery Of Embolics In Cancer Treatment
3. Saladax Biomedical Receives $22.4 Million Strategic Equity Investment From Shanghai Fosun Pharmaceutical
4. Leviton Introduces Medical-Grade Power Strips for Use in Patient-Care Areas
5. Varian Medical Systems to Showcase Fast, Reliable, Wireless X-ray Image Detectors at the ECR Annual Meeting in Vienna Next Week
6. ROX Medical enrolls first patients in Ireland for CONTROL-HTN hypertension trial at Beaumont and Mater Private Hospitals
7. Aquavit Pharmaceuticals Inc. Appoints David Shafer, MD., FACS., New Chief Medical Technology Officer
8. Richard Wolf Medical Instruments Launches Narrow-Channel Reprocessing Training
9. Medical Alarm Concepts Provides Investor Update - Signs Deal with Health Care Insurance Provider for Medical Alarms
10. Medical Device Contract Manufacturing: World Market Outlook 2013-2023
11. SurgiCount Medical Launches New Surgical Sponge Product
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Ky. , Jan. 15, 2014  Manufacturers, suppliers ... must be able to protect their most important ... http://photos.prnewswire.com/prnh/20130716/CL46586LOGO ) Because of ... it steadfastly remains one of the most litigious ...
(Date:1/15/2014)... 2014  Echo Therapeutics, Inc. (Nasdaq: ECTE ) ... System as a non-invasive, wireless continuous glucose monitoring system, ... Chairman and Interim CEO of Echo Therapeutics, will present ... Conference. Mr. Doman will make a ...
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com ... is available in its catalogue: ... Drug Forecast and Market Analysis to 2022 ... PharmaPoint: Atopic Dermatitis - India Drug Forecast ...
Breaking Medicine Technology:Intellectual Property Insurance for Medical-related Products and Services 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5
... Inc.,(Nasdaq: MEDX ) today announced interim ... an investigational oncology immunotherapy, as monotherapy or ... castration,resistant prostate cancer (mCRPC). Data presented showed ... was clinically active and,generally well-tolerated. Preliminary evidence ...
... and REGENSBURG, Germany, June 2 "A ... in recurrent or refractory anaplastic,astrocytoma suggests a ... commented Prof. Ulrich Bogdahn, Neuro-Oncologist and Coordinating,Investigator ... with AP,12009 in recurrent or refractory high-grade ...
Cached Medicine Technology:Interim Phase 1/2 Data of Ipilimumab in Prostate Cancer Presented at American Society of Clinical Oncology Annual Meeting 2Interim Phase 1/2 Data of Ipilimumab in Prostate Cancer Presented at American Society of Clinical Oncology Annual Meeting 3Interim Phase 1/2 Data of Ipilimumab in Prostate Cancer Presented at American Society of Clinical Oncology Annual Meeting 4Clinical Proof of Concept for TGF-beta 2-Inhibitor AP 12009 in Phase Iib EMEA provides Guidance on Phase III Design and Approval Requirements 2Clinical Proof of Concept for TGF-beta 2-Inhibitor AP 12009 in Phase Iib EMEA provides Guidance on Phase III Design and Approval Requirements 3Clinical Proof of Concept for TGF-beta 2-Inhibitor AP 12009 in Phase Iib EMEA provides Guidance on Phase III Design and Approval Requirements 4
(Date:4/17/2014)... 2014 Giving patients adrenaline after they suffer a cardiac ... prospects of surviving long-term, according to new research conducted ... patients who have a cardiac arrest get adrenaline, which ... for decades," said Dr. Steve Lin, an emergency physician ... advances in medical treatment, long-term survival rates of patients ...
(Date:4/17/2014)... LSTM have called for more research to be ... children in sub-Saharan Africa. In a paper in ... Russell Stothard, working with colleagues in the department ... University, in Cleveland Ohio, University of Cambridge and ... into the joint burden of HIV/AIDS and schistosomiasis ...
(Date:4/16/2014)... Celldex Therapeutics, Inc. (NASDAQ: CLDX) announced today that final ... solid tumors, including long-term patient follow-up, have been published ... 232). The data demonstrate robust antibody and T cell ... very advanced cancers and suggest that CDX-1401 may predispose ...
(Date:4/16/2014)... it is well known that fertility treatments are the ... multiples are at elevated risk of premature birth, these ... Fertility and Sterility . The article identifies ... the odds of multiple births and prematurity, including expanding ...
(Date:4/15/2014)... , , CHAMPAIGN, Ill. Scientists have solved a decades-old medical mystery ... way to fight invasive fungal infections, which kill about 1.5 million ... of action of amphotericin, an antifungal drug that has been in ... nearly as toxic to human cells as it is to the ...
Breaking Medicine News(10 mins):Health News:Adrenaline does little to increase patient's survival after cardiac arrest 2Health News:More research called for into HIV and schistosomiasis coinfection in African children 2Health News:Celldex's Phase 1 study of CDX-1401 published in Science Translational Medicine 2Health News:Celldex's Phase 1 study of CDX-1401 published in Science Translational Medicine 3Health News:Celldex's Phase 1 study of CDX-1401 published in Science Translational Medicine 4Health News:Preterm births, multiples, and fertility treatment 2Health News:Preterm births, multiples, and fertility treatment 3Health News:Potent, puzzling and (now less) toxic: Team discovers how antifungal drug works 2Health News:Potent, puzzling and (now less) toxic: Team discovers how antifungal drug works 3
... BMR, TORONTO, Dec. 12 /PRNewswire-FirstCall/ - Bradmer ... and,commercialization of cancer therapies, today announced that Keith ... to join the Company,s Scientific,Advisory Board. Dr. Black ... America, having performed more than 5,000 operations for ...
... Patient organizations support extending MSP and using savings ... American Kidney Fund and DaVita Patient Citizens submit ... WASHINGTON, Dec. 12 -Kidney Care Partners --,a ... manufacturers working together to improve quality of care ...
... Asia, Africa may not apply to patients in the ... Disappointing the hopes of researchers, new trials using a ... little or no benefit from the drugs. , "It ... lecturer in infectious diseases at the University of Malawi ...
... movies and TV shows make light of womens so-called ... or, conversely, to menopause. In fact, mood disorders are ... studies have found women are 1.5 to 3 times ... are men. , In a newly published study, ...
... Scient,x USA, an innovative,leader in the development and marketing ... today that Bryce T. IntVeld has,joined the Company as ... provide leadership and oversee the establishment and expansion,of sales ... delighted to have Bryce as a member of our ...
... WASHINGTON, Dec. 12 The Long Term Care,Pharmacy ... policy voice,for pharmacies which specifically serve nursing home ... its membership to include LTC pharmacy,companies that serve ... living in 47 states., "LTCPA represents highly ...
Cached Medicine News:Health News:Bradmer announces additions to Scientific Advisory Board 2Health News:Bradmer announces additions to Scientific Advisory Board 3Health News:Kidney Patient Organizations, Kidney Community Come Out in Support of Medicare Secondary Payer (MSP) Extension 2Health News:Kidney Patient Organizations, Kidney Community Come Out in Support of Medicare Secondary Payer (MSP) Extension 3Health News:Steroid Fails to Ease Meningitis in Trials 2Health News:Steroid Fails to Ease Meningitis in Trials 3Health News:Experts call for better research into link between women's hormones and mood disorders 2Health News:Scient'x USA Strengthens Leadership Team With Appointment of Bryce IntVeld as Vice President of Sales 2Health News:Long Term Care Pharmacy Alliance Expands Membership; Members Now Serve Most of the Nation's Nursing Home Residents 2
The Editors and Contributors are a virtual "Who's Who" in surgery, and they have prepared an outstanding program that provides expert advice on a full range of problems. Destined to be the "gold stan...
The First Aid for the Surgery Clerkship is designed to prepare for the surgery clerkship examination and provides clinical diagnosis and treatment of many of the problems seen by surgeons....
CURRENT Consult: Surgery brings you authoritative clinical answers on more than 360 surgically treated disorders in the most efficient format, perfectly devised for the busy physician....
... enable all those involved with healthcare decisions ... very latest evidence in their field of ... each year as the volume of evidence ... delivering the best single source available for ...
Medicine Products: